CDC Recommends Hep B Vaccination for Most Adults CDC Recommends Hep B Vaccination for Most Adults
Faced with an increasing incidence of hepatitis B infection, the Centers for Disease Control and Prevention expanded its vaccination recommendation to include most adults.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 2, 2022 Category: Infectious Diseases Tags: Gastroenterology News Source Type: news
Risk for Acute MI Not Increased With Two-Dose HepB-CpG Vaccine
FRIDAY, April 1, 2022 -- The rate of type 1 acute myocardial infarction (MI) is not increased with receipt of the two-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG vaccine) versus the three-dose hepatitis B vaccine with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2022 Category: Pharmaceuticals Source Type: news
Universal HepB Vaccination Recommended for Adults Age 19 to 59
THURSDAY, March 31, 2022 -- Hepatitis B (HepB) vaccination should be administered to adults aged 19 to 59 years and to those aged 60 years or older with risk factors for HepB, according to updated recommendations published in the April 1 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2022 Category: Pharmaceuticals Source Type: news
Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
This report describes updated hepatitis B vaccination recommendations from the Advisory Committee on Immunization Practices. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 31, 2022 Category: American Health Tags: Advisory Committee on Immunization Practices (ACIP) Hepatitis B MMWR Morbidity & Mortality Weekly Report Source Type: news
Reassuring Data on Two-Dose Hep B Vaccine, Risk of Acute MI
(MedPage Today) -- There was no higher risk of heart attack for recipients of the two-dose hepatitis B cytosine phosphoguanine adjuvant vaccine (Heplisav-B) compared to the three-dose hepatitis B vaccine with an aluminum hydroxide adjuvant (Engerix... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 28, 2022 Category: Gastroenterology Source Type: news
Public Health Catastrophe Looms in Ukraine, Experts Warn
Even before the war, the country struggled with epidemics of H.I.V., tuberculosis and hepatitis. The conflict threatens to undo decades of progress. (Source: NYT Health)
Source: NYT Health - March 26, 2022 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Russian Invasion of Ukraine (2022) Coronavirus (2019-nCoV) Tuberculosis Acquired Immune Deficiency Syndrome War and Armed Conflicts Refugees and Displaced Persons Epidemics Vaccination and Immunization Drug Resistance ( Source Type: news
Ghana: Over 200 Vaccinated Against Hepatitis B in Wa Communities
[Ghanaian Times] Wa -- More than 200 people have been vaccinated against Hepatitis B in the last 10 months in six communities in the Wa Municipality and the Wa East District of the Upper West Region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 18, 2022 Category: African Health Source Type: news
EMA Recommends PreHevbri Hepatitis B Vaccine for Approval EMA Recommends PreHevbri Hepatitis B Vaccine for Approval
The three-antigen hepatitis B vaccine received approval from the FDA in November 2021.International Approvals (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - March 1, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news
U.S. FDA Approves CARVYKTI ™ (ciltacabtagene autoleucel), Janssen’s First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
HORSHAM, Pa., February 28, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel) for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.1 The approval is based on data from the pivotal CARTITUDE-1 study, which included patients who had received a median of six prior treatment regimens (range, 3-18), and had previously rec...
Source: Johnson and Johnson - March 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
ACIP Issues Adult Vaccination Schedule 2022 ACIP Issues Adult Vaccination Schedule 2022
Changes affect zoster, pneumococcal, and hepatitis B vaccines, and COVID-19 is now included.News Alerts (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 17, 2022 Category: Allergy & Immunology Tags: Internal Medicine News Alert Source Type: news
Hep B Testing, Vaccine Seen Cost-Effective in Pregnant Women Hep B Testing, Vaccine Seen Cost-Effective in Pregnant Women
Although vaccination is not routine during pregnancy, guidelines from ACOG state that at-risk women should be screened and vaccinated for hepatitis B during pregnancy.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 11, 2022 Category: Infectious Diseases Tags: Ob/Gyn & Women ' s Health News Source Type: news
Mozambique: Maputo Study On Cutting Mother to Child Transmission of Hepatitis B
[AIM] A study carried out in Maputo has shown that antenatal departments can cut the transmission of the hepatitis B virus (HBV) from mother to child through integrating vaccination at birth into standard procedures. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 19, 2022 Category: African Health Source Type: news
Comvax (Haemophilus b Conjugate and Hepatitis B Vaccine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 13, 2022 Category: Drugs & Pharmacology Source Type: news
The FDA Just Authorized the First COVID-19 Pill, a Pfizer Drug That Can Be Taken At Home
U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.
The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that could overwhelm hospitals.
The drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited. All of the previously authorized drugs against the disease require an IV or an injection.
[time-brightcove not-...
Source: TIME: Health - December 22, 2021 Category: Consumer Health News Authors: MATTHEW PERRONE / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
PreHevbrio (Hepatitis B Vaccine (Recombinant) Injectable Suspension) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 20, 2021 Category: Drugs & Pharmacology Source Type: news
